Rancho Cucamonga, CA1 Active Studies

Ulcerative Colitis Clinical Trials in Rancho Cucamonga, CA

Find 1 actively recruiting ulcerative colitis clinical trials in Rancho Cucamonga, CA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
140
Enrolling

Recruiting Ulcerative Colitis Studies in Rancho Cucamonga

About Ulcerative Colitis Clinical Trials in Rancho Cucamonga

Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.

There are currently 1 ulcerative colitis clinical trials recruiting participants in Rancho Cucamonga, CA. These studies are seeking a combined 140 participants. Research is being sponsored by Eli Lilly and Company. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ulcerative Colitis Clinical Trials in Rancho Cucamonga — FAQ

Are there ulcerative colitis clinical trials in Rancho Cucamonga?

Yes, there are 1 ulcerative colitis clinical trials currently recruiting in Rancho Cucamonga, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rancho Cucamonga?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rancho Cucamonga research site will contact you about next steps.

Are clinical trials in Rancho Cucamonga free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rancho Cucamonga studies also compensate for your time and travel.

What ulcerative colitis treatments are being tested?

The 1 active trials in Rancho Cucamonga are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.

Data updated March 2, 2026 from ClinicalTrials.gov